Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Germany · Delayed Price · Currency is EUR 0.9650
+0.0050 (0.52%)
Aug 5, 2026, 5:35 PM CET
ETR:MAK Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.87 | 2.88 | 0.55 | 2.06 | 12.49 |
Short-Term Investments | 4.6 | 4.71 | 6.65 | 8.89 | 4.64 |
Cash & Short-Term Investments | 8.47 | 7.58 | 7.2 | 10.95 | 17.13 |
Cash Growth | 11.71% | 5.31% | -34.28% | -36.07% | 19.29% |
Accounts Receivable | 10.21 | 8.49 | 14.88 | 4.8 | 4.51 |
Other Receivables | 0.38 | 0.5 | 0.62 | 0.48 | 0.35 |
Total Trade Receivables | 10.59 | 9 | 15.51 | 5.28 | 4.86 |
Inventory | 0.41 | 0.41 | 0.59 | 0.59 | 0.6 |
Other Current Assets | 0.17 | 0.04 | 0.25 | 0.07 | 0.09 |
Total Current Assets | 19.63 | 17.02 | 23.54 | 16.89 | 22.69 |
Net Property, Plant & Equipment | 116.43 | 109.17 | 116.43 | 121.27 | 128.45 |
Other Intangible Assets | 13.21 | 13.21 | 13.24 | 13.31 | 13.37 |
Long-Term Investments | 0.6 | 0.47 | 1.16 | 1.94 | 0.54 |
Other Long-Term Assets | - | - | - | - | 0.37 |
Total Assets | 149.87 | 139.88 | 154.38 | 153.4 | 165.41 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.05 | 3.7 | 5.26 | 4.83 | 4.64 |
Accrued Expenses | 7.79 | 3.43 | 3.83 | 6.85 | 6.17 |
Short-Term Debt | 72.92 | 117.8 | 59.47 | 36.79 | 23.15 |
Current Portion of Long-Term Debt | - | - | - | - | 7.38 |
Unearned Revenue | 0.8 | 0.74 | 0.73 | 0.67 | 0.78 |
Other Current Liabilities | 8.47 | 7.15 | 8.15 | 7.19 | 5.15 |
Total Current Liabilities | 94.03 | 132.82 | 77.44 | 56.33 | 47.27 |
Long-Term Debt | 132.31 | 69.68 | 127.98 | 133.52 | 138.46 |
Other Long-Term Liabilities | 2.64 | 2.63 | 1.07 | 1.1 | 1.03 |
Total Long-Term Liabilities | 136.43 | 73.9 | 130.7 | 136.37 | 143.49 |
Total Liabilities | 230.46 | 206.72 | 208.14 | 192.7 | 190.76 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 51.94 | 51.94 | 51.94 | 51.94 | 51.94 |
Additional Paid-in Capital | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 |
Accumulated Other Comprehensive Income | -0.42 | -0.52 | -0.6 | -0.54 | - |
Retained Earnings | -135.87 | -122.02 | -108.87 | -94.47 | -81.05 |
Total Common Shareholders' Equity | -80.59 | -66.84 | -53.76 | -39.3 | -25.34 |
Minority Interest | 1.48 | 1.59 | 1.64 | 1.75 | 4 |
Shareholders' Equity | -79.11 | -65.25 | -52.12 | -37.55 | -21.34 |
Total Liabilities & Equity | 149.87 | 139.88 | 154.38 | 153.4 | 165.41 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 205.24 | 187.48 | 187.45 | 170.31 | 168.99 |
Net Cash (Debt) | -196.77 | -179.9 | -180.25 | -159.36 | -151.86 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -9.38 | -8.58 | -8.60 | -7.60 | -7.24 |
Book Value | -80.59 | -66.84 | -53.76 | -39.3 | -25.34 |
Book Value Per Share | -3.84 | -3.19 | -2.56 | -1.87 | -1.21 |
Tangible Book Value | -93.8 | -80.05 | -67 | -52.61 | -38.71 |
Tangible Book Value Per Share | -4.47 | -3.82 | -3.19 | -2.51 | -1.85 |